Fukuoka, Japan

Naoyuki Watanabe

This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Api Corporation. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoyuki Watanabe. Retrieved from https://idiyas.com/inventor/naoyuki-watanabe-vtx7deqd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0


Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Naoyuki Watanabe: Innovator in Pharmaceutical Production

Introduction

Naoyuki Watanabe is a prolific inventor based in Fukuoka, Japan. He has made significant contributions to the pharmaceutical industry, holding five patents that focus on efficient production methods of important medications. His work exemplifies the intersection of innovation and practicality in drug manufacturing.

Latest Patents

Watanabe's latest patents include groundbreaking methods for producing critical medications with enhanced efficiency and reduced costs. One of his notable inventions is related to Rosuvastatin calcium, where he outlines a novel method capable of producing this compound and its intermediates efficiently, inexpensively, and with high purity. The method eliminates the need for extremely low-temperature reactions or special asymmetric catalysts, making the production process both innovative and accessible.

Another significant patent involves the production of Pitavastatin calcium. This patent details a process ensuring safe industrial-scale production at a high yield and selectivity while maintaining low costs. The method comprises three main steps: acetalizing a specific compound, reacting it with an acid, and hydrolyzing it to create Pitavastatin calcium. This efficient production method has the potential to streamline processes in pharmaceutical manufacturing.

Career Highlights

Naoyuki Watanabe has built a strong career at Api Corporation, where he continues to develop innovative solutions for pharmaceutical production challenges. His work has had a considerable impact on improving the efficiency and purity of drug manufacturing, contributing to the accessibility of vital medications.

Collaborations

Throughout his career, Watanabe has collaborated with fellow researchers and professionals, including Masaki Nagahama and Takanobu Iura. These collaborations foster an environment of innovation, where ideas can be exchanged and refined to lead to further advancements in pharmaceutical technologies.

Conclusion

Naoyuki Watanabe stands out as a significant figure in the field of pharmaceutical innovation. His inventions not only aim to enhance production processes but also focus on cost-effectiveness and purity, embodying the spirit of innovation that drives the industry forward. As he continues his work at Api Corporation, his contributions are likely to yield further advancements in pharmaceuticals, reinforcing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…